|
"楊志新"的相关文件
显示项目 96-145 / 209 (共5页)
<< < 1 2 3 4 5 > >>
每页显示[10|25|50]项目
| 國立臺灣大學 |
2012 |
Effusion Immunocytochemistry as an Alternative Approach for the Selection of First-Line Targeted Therapy in Advanced Lung Adenocarcinoma
|
Tsai, Tzu-Hsiu; Wu, Shang-Gin; Chang, Yih-Leong; Wu, Chen-Tu; Tsai, Meng-Feng; Wei, Pin-Fei; Yang, Chih-Hsin; Yu, Chong-Jen; Yang, Pan-Chyr; Shih, Jin-Yuan; 吳振都; 楊志新; 張逸良; 楊泮池; 余忠仁; 衛品妃; 吳尚俊; 蔡子修; 施金元 |
| 國立臺灣大學 |
2012 |
Genetic Polymorphism of XRCC1 Arg399Gln Is Associated With Survival in Non-Small-Cell Lung Cancer Patients Treated With Gemcitabine/Platinum
|
Liao, Wei-Yu; Shih, Jin-Yuan; Chang, Gee-Chen; Cheng, Yu-Kai; Yang, James Chih-Hsin; Chen, Yuh-Min; Yu, Chong-Jen; 楊志新; 廖唯昱; 余忠仁; 施金元 |
| 國立臺灣大學 |
2012 |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
Chang, Yeun-Chung; Yu, Chong-Jen; Chen, Chung-Ming; Hu, Fu-Chang; Hsu, Hao-Hsiang; Tseng, Wen-Yih I.; Shih, Tiffany Ting-Fang; Yang, Pan-Chyr; Yang, James Chih-Hsin; 曾文毅; 楊志新; 陳中明; 張允中; 施庭芳; 楊泮池; 余忠仁; 胡賦強 |
| 國立臺灣大學 |
2012 |
Factors Impacting Prognosis Prediction in BCLC Stage C and Child-Pugh Class A Hepatocellular Carcinoma Patients in Prospective Clinical Trials of Systemic Therapy
|
Lin, Zhong-Zhe; Hsu, Chiun; Hu, Fu-Chang; Shao, Yu-Yun; Chang, Dwan-Ying; Yang, Chih-Hsin; Hong, Ruey-Long; Hsu, Chih-Hung; Cheng, Ann-Lii; 楊志新; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 洪瑞隆; 許駿; 胡賦強; 張端瑩 |
| 國立臺灣大學 |
2012 |
Advanced non-small cell lung cancer in patients aged 45 years or younger: outcomes and prognostic factors
|
Hsu, Chia-Lin; Chen, Kuan-Yu; Shih, Jin-Yuan; Ho, Chao-Chi; Yang, Chih-Hsin; Yu, Chong-Jen; Yang, Pan-Chyr; 楊志新; 楊泮池; 許嘉林; 陳冠宇; 余忠仁; 何肇基; 施金元 |
| 國立臺灣大學 |
2012 |
Survival Following Surgery with or without Adjuvant Chemotherapy for Stage I-IIIA Non-Small Cell Lung Cancer: An East Asian Population-Based Study
|
Lin, Zhong-Zhe; Shau, Wen-Yi; Shao, Yu-Yun; Yang, Yen-Yun; Kuo, Raymond Nien-Chen; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 林宗哲 |
| 國立臺灣大學 |
2012 |
Survival of Patients with Small Cell Lung Carcinoma in Taiwan
|
Kuo, Yu-Hsuan; Lin, Zhong-Zhe; Yang, Yen-Yun; Shao, Yu-Yun; Shau, Wen-Yi; Kuo, Raymond N. C.; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 林宗哲; 郭年真 |
| 國立臺灣大學 |
2012 |
Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma
|
Girard, N.; Sima, C. S.; Jackman, D. M.; Sequist, L. V.; Chen, H.; Yang, J. C-H.; Ji, H.; Waltman, B.; Rosell, R.; Taron, M.; Zakowski, M. F.; Ladanyi, M.; Riely, G.; Pao, W.; 楊志新 |
| 國立臺灣大學 |
2012 |
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial
|
Miller, Vincent A.; Hirsh, Vera; Cadranel, Jacques; Chen, Yuh-Min; Park, Keunchil; Kim, Sang-We; Zhou, Caicun; Su, Wu-Chou; Wang, Mengzhao; Sun, Yan; Heo, Dae Seog; Crino, Lucio; Tan, Eng-Huat; Chao, Tsu-Yi; Shahidi, Mehdi; Cong, Xiuyu Julie; Lorence, Robert M.; Yang, James Chih-Hsin; 楊志新 |
| 國立臺灣大學 |
2011 |
Comparison of the Quality of Life between Patients with Non-Small-Cell Lung Cancer and Healthy Controls
|
李俊賢; 張郁瑩; 李元麒; 楊志新; 劉紹興; 劉邦祥; 王榮德; LEE, LUKAS JYUHN-HSIARN; CHANG, YU-YIN; LEE, YUNG-CHIE; YANG, CHIH-HSIN; LIOU, SAOU-HSING; LIU, PANG-HSIANG; WANG, JUNG-DER |
| 國立臺灣大學 |
2011 |
Tumour Response, Skin Rash and Health-Related Quality of Life (Hrqol) - Post-Hoc Data from the Ipass Study
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2011 |
Skin Manifestations of Gefitinib and the Association with Survival of Advanced Non-Small-Cell Lung Cancer in Taiwan
|
王修含; 楊志新; 邱顯清; 胡賦?; 詹智傑; 廖怡華; 陳小菁; 朱家瑜; WANG, SHIOU-HAN; YANG, CHIH-HSIN; CHIU, HSIEN-CHING; HU, FU-CHANG; CHAN, CHIH-CHIEH; LIAO, YI-HUA; CHEN, HSIAO-CHIN; CHU, CHIA-YU |
| 國立臺灣大學 |
2011 |
Inspire: A Phase Iii Study of the Blp25 Liposome Vaccine (L-Blp25) in Asian Patients with Unresectable Stage Iii Non-Small Cell Lung Cancer
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2011 |
Phase 2 Trial of Linifanib (Abt-869) in Patients with Advanced Non-Small Cell Lung Cancer
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2011 |
Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non- Small-Cell Lung Cancer: A Randomized, Double-Blind Phase Iii Trial
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2011 |
Health-Related Quality-of-Life in a Randomized Phase Iii First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients from Asia with Advanced Nsclc (Ipass)
|
楊志新; 陳育民; 郭漢彬; YANG, CHIH-HSIN; CHEN, YUH-MIN; KUO, HAN-PIN |
| 國立臺灣大學 |
2011 |
Biomarker Analyses and Final Overall Survival Results from a Phase Iii, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/ Paclitaxel in Clinically Selected Patients with Advanced Non-Small-Cell Lung Cancer in Asia (Ipass)
|
楊志新; 趙祖怡; YANG, CHIH-HSIN; CHAO, TSU-YI |
| 國立臺灣大學 |
2010 |
Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors
|
陳冠宇; 陳人豪; 施金元; 楊志新; 余忠仁; 楊泮池; CHEN, KUAN-YU; CHEN, JEN-HAU; SHIH, JIN-YUAN; YANG, CHIH-HSIN; YU, CHONG-JEN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2010 |
O-6-Methylguanine-DNA Methyltransferase Expression and Prognostic Value in Brain Metastases of Lung Cancers
|
吳佩芳; 郭冠廷; 郭律廷; 林怡婷; 盧彥伸; 楊志新; 吳瑞美; 杜永光; 蔡瑞章; 曾漢民; 曾勝弘; 鄭安理; 林璟宏; WU, PEI-FANG; KUO, KUAN-TING; KUO, LU-TING; LIN, YI-TING; LU, YEN-SHEN; YANG, CHIH-HSIN; WU, RUEY-MEEI; TU, YONG-KWANG; TSAI, JUI-CHANG; TSENG, HAN-MIN; TSENG, SHENG-HONG; CHENG, ANN-LII; LIN, CHING-HUNG |
| 國立臺灣大學 |
2010 |
Characteristics and Risk Factors of Oxaliplatin-Related Hypersensitivity Reactions
|
邵幼雲; 胡賦强; 邱文姿; 鄭安理; 楊志新; SHAO, YU-YUN; HU, FU-CHANG; CHIU, WEN-TZU; CHENG, ANN-LII; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2010 |
Chemotherapy Response in East Asian Non-Small Cell Lung Cancer Patients Harboring Wild-Type or Activating Mutation of Epidermal Growth Factor Receptors
|
林家齊; 徐心馨; 孫家棟; 施金元; 林宗哲; 余忠仁; 楊志新; LIN, CHIA-CHI; HSU, HSIN-HSIN; SHUN, CHIA-TUNG; SHIH, JIN-YUAN; LIN, ZONG-ZHE; YU, CHONG-JEN; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2010 |
Correlation of F-18 Fluorodeoxyglucose-Positron Emission Tomography Maximal Standardized Uptake Value and Egfr Mutations in Advanced Lung Adenocarcinoma
|
黃俊達; 顏若芳; 鄭媚方; 衛品妃; 蔡怡汝; 蔡孟峰; 施金元; 楊志新; 楊泮池; HUANG, CHUN-TA; YEN, RUOH-FANG; CHENG, MEI-FANG; WEI, PIN-FEI; TSAI, YI-JU; TSAI, MENG-FENG; SHIH, JIN-YUAN; YANG, CHIH-HSIN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2010 |
Influence of First-Line Chemotherapy and Egfr Mutations on Second-Line Gefitinib in Advanced Non-Small Cell Lung Cancer
|
巫震宇; 余忠仁; 施金元; 楊志新; 楊泮池; WU, JENN-YU; YU, CHONG-JEN; SHIH, JIN-YUAN; YANG, CHIH-HSIN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2010 |
Second-Line Treatments after First-Line Gefitinib Therapy in Advanced Nonsmall Cell Lung Cancer
|
巫震宇; 施金元; 楊志新; 陳冠宇; 何肇基; 余忠仁; 楊泮池; WU, JENN-YU; SHIH, JIN-YUAN; YANG, CHIH-HSIN; CHEN, KUAN-YU; HO, CHAO-CHI; YU, CHONG-JEN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2010 |
Use of Cetuximab after Failure of Gefitinib in Patients with Advanced Non- Small-Cell Lung Cancer
|
巫震宇; 楊志新; 余忠仁; 楊泮池; 施金元; WU, JENN-YU; YANG, CHIH-HSIN; YU, CHONG-JEN; SHIH, JIN-YUAN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2010 |
Quality of Life (Qol) in a Randomized Phase Iii First-Line Study of Gefitinib (G) Vs Carboplatin/Paclitaxel (Cp) in Clinically Selected Asian Patients (Pts) with Advanced Nsclc (Ipass)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2010 |
Final Overall Survival Os Results from a Phase Iii, Randomised, Open-Label , First-Line Study of Gefitinib G V Carboplatin/Paclitaxel C/P in Clinically Selected Patients with Advanced Non-Small Cell Lung Cancer Nsclc in Asia Ipass
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2010 |
Phase 2 Results of Xl184 in a Cohort of Patients Pts with Advanced Non- Small Cell Lung Cancer Nsclc
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Bibw 2992, a Novel Irreversible Egfr/Her2 Tyrosine Kinase Inhibitor, in Chemonaive Patients with Adenocarcinoma of the Lung and Activating Egfr Mutations
|
楊志新; 施金元; 蘇五洲; 夏德椿; YANG, CHIH-HSIN; SHIH, JIN-YUAN; SU, WU- CHOU; HSIA, TE-CHUN |
| 國立臺灣大學 |
2009 |
Clinical Outcomes of Patients with Epidermal Growth Factor Receptor (Egfr ) Mutations (Mut) in Ipass (Iressatm Pan Asia Study)
|
趙祖怡; 楊志新; CHAO, TSU-YI; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Vandetanib Plus Pernetrexed Versus Pemetrexed as 2nd-Line Therapy in Patients with Advanced Nsclc: A Randomized, Double-Blind Phase Iii Trial ( Zeal)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
An Open-Label Single-Arm Phase Iv Study of Pemetrexed in Taiwanese Patients with Advanced Non-Small Cell Lung Cancer Who Have Had Prior Chemotherapy
|
張基晟; 蔡俊明; 夏德椿; 楊志新; CHANG, GEE-CHEN; TSAI, CHUN-MING; HSIA, TE-CHUN; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Vandetanib Plus Pemetrexed Vs Pemetrexed as 2nd-Line Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (Nsclc); a Randomized, Double- Blind Phase Iii Trial
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Melatonin Inhibits Arsenite-Induced Peripheral Neurotoxicity
|
林滿玉; 范素芬; 趙珮玲; 楊志新; LIN, A. MAAN-YUH; FANG, SU-FEN; CHAO, PEI -LING; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
First-Line Systemic Treatment of Advanced Stage Non-Small-Cell Lung Cancer in Asia: Consensus Statement from the Asian Oncology Summit 2009
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Comparison of Epidermal Growth Factor Receptor Mutations between Primary and Corresponding Metastatic Tumors in Tyrosine Kinase Inhibitor-Naive Non -Small-Cell Lung Cancer
|
高劍虹; 張逸良; 蔡孟峰; 吳振都; 余忠仁; 楊志新; 李元麒; 楊泮池; 施金元; GOW, CHIEN-HUNG; CHANG, YIH-LEONG; TSAI, MENG-FENG; WU, CHEN-TU; YU, CHONG-JEN; YANG, CHIH-HSIN; LEE, YUNG-CHIE; YANG, PAN-CHYR; SHIH, JIN-YUAN |
| 國立臺灣大學 |
2009 |
Egfr Intron 1 Dinucleotide Repeat Polymorphism Is Associated with the Occurrence of Skin Rash with Gefitinib Treatment
|
黃敬倫; 楊志新; 葉坤輝; 胡賦强; 陳冠宇; 施金元; 林宗哲; 余忠仁; 鄭安理; 楊泮池; HUANG, CHING-LUN; YANG, CHIH-HSIN; YEH, KUN-HUEI; HU, FU-CHANG; CHEN, KUAN-YU; SHIH, JIN-YUAN; LIN, ZONG-ZHE; YU, CHONG-JEN; CHENG, ANN-LII; YANG, PAN-CHYR |
| 國立臺灣大學 |
2009 |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Elderly or Poor Performance Status Patients with Advanced Non-Small Cell Lung Cancer
|
林家齊; 楊志新; LIN, CHIA-CHI; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
National Center of Excellence for Clinical Trials and Research at National Taiwan University Hospital
|
林家齊; 楊志新; 鄭安理; 陳榮楷; 何弘能; LIN, CHIA-CHI; YANG, CHIH-HSIN; CHENG, ANN-LII; CHAN, WING-KAI; HO, HONG-NERNG |
| 國立臺灣大學 |
2009 |
Quality of Life in Advanced Non-Small Cell Lung Cancer Patients Receiving First-Line Gefitinib Monotherapy
|
邵幼雲; 林宗哲; 胡賦强; 余忠仁; 施金元; 胡文郁; 張逸良; 鄭安理; 楊泮池; 楊志新; SHAO, YU-YUN; LIN, ZONG-ZHE; HU, FU-CHANG; YU, CHONG-JEN; SHIH, JIN-YUAN; HU, WEN-YU; CHANG, YIH-LEONG; CHENG, ANN-LII; YANG, PAN-CHYR; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
A Phase Ii Study of Bibw 2992, a Novel Irreversible Dual Egfr and Her2 Tyrosine Kinase Inhibitor (Tki), in Patients with Adenocarcinoma of the Lung and Activating Egfr Mutations after Failure of One Line of Chemotherapy (Lux-Lung 2)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Biomarker Analyses from a Phase Iii, Randomized, Open-Label, First-Line Study of Gefitinib (G) Versus Carboplatin/Paclitaxel (C/P) in Clinically Selected Patients (Pts) with Advanced Non-Small Cell Lung Cancer (Nsclc) in Asia (Ipass)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Efficacy of Pemetrexed-Cisplatin (Pc) in East Asian Patients (Pts): Subgroup Analysis of a Phase Iii Study Comparing Pc Versus Gemcitabine- Cisplatin (Gc) in First-Line Treatment of Advanced Non-Small Cell Lung Cancer (Nsclc)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Phase Iib/Iii Double-Blind Randomized Trial of Bibw 2992, an Irreversible, Dual Inhibitor of Egfr and Her2 Plus Best Supportive Care (Bsc) Versus Placebo Plus Bsc in Patients with Nsclc Failing 1-2 Lines of Chemotherapy (Ct) and Erlotinib or Gefitinib (Lu
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2009 |
Vandetanib Plus Pemetrexed Versus Pemetrexed as Second-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer (Nsclc): A Randomized, Double-Blind Phase Iii Trial (Zeal)
|
楊志新; YANG, CHIH-HSIN |
| 臺大學術典藏 |
2009 |
First-Line Systemic Treatment of Advanced Stage Non-Small-Cell Lung Cancer in Asia: Consensus Statement from the Asian Oncology Summit 2009
|
楊志新; Soo, Ross A; Anderson, Benjamin O; Cho, Byoung Chul; Yang, Chih-Hsin; Liao, Meilin; Lim, Wan-Teck; Goldstraw, Peter; Mok, Tony S; Soo, Ross A; Anderson, Benjamin O; Cho, Byoung Chul; Yang, Chih-Hsin; Liao, Meilin; Lim, Wan-Teck; Goldstraw, Peter; Mok, Tony S |
| 國立臺灣大學 |
2008-07-31 |
非小細胞肺癌對表皮生長因子接受器抑制劑抗藥性之研究 （新制多年期第1年）
|
楊志新 |
| 國立臺灣大學 |
2008-06 |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin, Zhong-Zhe; Hsu, Chiun; Chang, Yeun-Chung; Yu, Chong-Jen; Hsu, Chih-Hung; Lin, Chia-Chi; Cheng, Ann-Lii; Yang, Pan-Chyr; Yang, Chih-Hsin; 林宗哲; 許駿; 張允中; 余忠仁; 徐志宏; 林家齊; 鄭安理; 楊泮池; 楊志新 |
| 中國醫藥大學 |
2008-03-29 |
肺癌病人接受根治性胸腔放療之預後
|
簡君儒(Chun-Ru Chien); 楊志新; 余忠仁* |
显示项目 96-145 / 209 (共5页)
<< < 1 2 3 4 5 > >>
每页显示[10|25|50]项目
|
